0484: The LEADERS FREE Trial: a double blind randomized comparison of a BMS and a polymer-free Drug Coated Stent (DCS) in 2,466 patients at high bleeding risk and treated with one month DAPT only
Conclusion The trial focuses on a never previously studied high bleeding risk population characterized by advanced age and more comorbid conditions. It is the 1st evaluation of a DCS with clinical endpoints and comprises the shortest ever DAPT course with an active stent to be evaluated for both safety and efficacy.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
More News: Anemia | Atrial Fibrillation | Bleeding | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Chronic Obstructive Pulmonary | Diabetes | Endocrinology | Heart | Heart Failure | Oral Cancer | Peripheral Vascular Disease (PVD) | Stroke | Thrombosis